GODAVARI

Godavari Drugs Share Price

 

 

Start SIP in GODAVARI

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume
  • 50 DMA₹81.86
  • 100 DMA₹82.79
  • 200 DMA₹87.03

Investment Returns

  • Over 1 Month + 43.02%
  • Over 3 Month + 26.09%
  • Over 6 Month + 14.94%
  • Over 1 Year -3.76%

Smart Investing Starts Here Start SIP with Godavari Drugs for Steady Growth!

Invest Now

Godavari Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Godavari Drugs Financials

Godavari Drugs Technicals

EMA & SMA

Current Price
₹102.30
+ 14.08 (15.96%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹84.80
  • 50 Day
  • ₹81.86
  • 100 Day
  • ₹82.79
  • 200 Day
  • ₹87.03

Resistance and Support

98.79 Pivot Speed
  • R3 125.17
  • R2 115.29
  • R1 108.67
  • S1 92.17
  • S2 82.29
  • S3 75.67

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Godavari Biorefineries Ltd has an operating revenue of Rs. 1,990.76 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 0% needs improvement, ROE of -2% is poor and needs improvement. The company has a reasonable debt to equity of 31%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 5% and 10% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 19% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 40 which is a POOR score indicating inconsistency in earnings, a RS Rating of 85 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 112 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Godavari Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-15 Preferential issue of shares
2025-11-14 Quarterly Results
2025-08-13 Quarterly Results & A.G.M.
2025-05-29 Audited Results
2025-02-12 Quarterly Results

Godavari Drugs F&O

Godavari Drugs Shareholding Pattern

63.31%
10.86%
0%
0.6%
19.11%
6.12%

About Godavari Drugs

  • NSE Symbol
  • GODAVARI
  • BSE Symbol
  • 530317
  • Chairman & Managing Director
  • Mr. Samir Shantilal Somaiya
  • ISIN
  • INE362C01012

Similar Stocks to Godavari Drugs

Godavari Drugs FAQs

Godavari Drugs share price is ₹102 As on 16 January, 2026 | 23:24

The Market Cap of Godavari Drugs is ₹77 Cr As on 16 January, 2026 | 23:24

The P/E ratio of Godavari Drugs is 20.8 As on 16 January, 2026 | 23:24

The PB ratio of Godavari Drugs is 1.7 As on 16 January, 2026 | 23:24

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23